New program tackles stigma to get more women with HIV screened for cervical cancer
NCT ID NCT05736588
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a program called Elimisha HPV, designed to reduce stigma and increase cervical cancer screening among women living with HIV in Kenya. The program included simple educational scripts, a video addressing fears, and peer support. Nearly 1,000 women participated, and researchers measured how many got screened for HPV and followed up for treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Elimisha HPV (behavioral intervention: education, peer navigation, patient-centered delivery)
What this could lead to
If successful, this model could increase cervical cancer screening rates among women living with HIV, reducing cancer risk in a high-stigma population.
What could go wrong
This is a completed behavioral study, not a drug trial. Results may not apply outside Kenya or to other populations. Stigma reduction is complex and hard to scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kenya Medical Research Institute
Kisumu, Kenya